DBVT Q1 2024 Earnings — DBV Technologies S.A. Revenue & Financial Results | Market Cap Arena

DBVTDBV Technologies S.A.

$560M

Q1 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M-35.9% YoY

Gross Profit

$1M100.0% margin

Operating Income

-$29M-2029.7% margin

Net Income

-$27M-1943.5% margin

EPS (Diluted)

$-1.40

QoQ Revenue Growth

-84.1%

Cash Flow

Operating Cash Flow

-$35M

Free Cash Flow

-$36M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$146M

Total Liabilities

$34M

Stockholders' Equity

$112M

Cash & Equivalents

$102M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$2M	-35.9%
Gross Profit	$1M	$2M	-35.9%
Operating Income	-$29M	-$21M	-34.9%
Net Income	-$27M	-$21M	-33.0%